Paolo Paoletti

Paoletti, 68, was coaxed out of academic medicine to join Eli Lilly’s oncology unit. He eventually became vice-president of the company before moving to pharma giant Glaxo Smith Kline. Today he is chief executive of one of London’s most exciting biotech companies — GammaDelta Therapeutics — which is on the front line of cancer research. It has already won $100m of investment from backers including Japanese pharma giant Takeda.

Maserati S.p.A.
Viale Ciro Menotti, 322 – 41121, Modena (MO), Italy

Company registered under Italian law - VAT: IT 08245890010 R.E.A. Modena 347990

Share capital: 80.000.000 €, fully paid-up
Direction and coordination under Article 2497 of the Italian Civil Code: Stellantis N.V.

maserati@pec.fcagroup.com
www.maserati.com